ARTICLE SUMMARY:
Executive Editor David Filmore introduces our new publication covering the global regulatory, reimbursement, and market access environment for medtech.
A message to medical device makers: your pick of market pathways is growing in volume and complexity. Some are newly placed express lanes. Others are freshly fitted with speed bumps. And some pathways face the prospect of major bumper-to-bumper traffic. But getting from Point A to Point B in medtech is not what it used to be—there are more decisions, more demands, and more data.
